ITRM - Iterum Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/2016
Net Income-77,056-29,406-13,464
Operating Activities, Cash Flows Provided By or Used In
Depreciation1366565
Adjustments To Net Income2,273341348
Changes In Accounts Receivables---
Changes In Liabilities8491,6711,188
Changes In Inventories---
Changes In Other Operating Activities-2,572-3,281647
Total Cash Flow From Operating Activities-75,890-30,604-11,298
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-90-812-812
Investments-8,568-30,775-30,775
Other Cash flows from Investing Activities---
Total Cash Flows From Investing Activities-8,658-31,587-31,587
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid---
Sale Purchase of Stock---
Net Borrowings14,50714,50714,507
Other Cash Flows from Financing Activities---
Total Cash Flows From Financing Activities120,84245,86720,851
Effect Of Exchange Rate Changes-108-108-108
Change In Cash and Cash Equivalents36,186-16,3249,553